Apple Inc.
$3.99T- Market cap
- $3.95T
- Debt
- +$80.11B
- Cash
- −$36.31B
Capital structure 98% equity / 2% debt · EV / Revenue 8.34x · EV proxy / EBITDA proxy 23.29x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: AAPL stock price vs CVS: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at CVS's multiple
Needs CVS P/E.
Implied fair value · at AAPL's multiple
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
17 period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Capital structure 98% equity / 2% debt · EV / Revenue 8.34x · EV proxy / EBITDA proxy 23.29x
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Apple Inc. · implied price per share
Bear
$130.85
Base
$159.76
Bull
$182.30
CVS HEALTH Corp · implied price per share
Bear
$43.35
Base
$58.49
Bull
$78.21
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
MICROSOFT CORP
AAPL vs MSFT
Alphabet Inc.
AAPL vs GOOGL
Meta Platforms, Inc.
AAPL vs META
NVIDIA CORP
AAPL vs NVDA
INTEL CORP
AAPL vs INTC
CISCO SYSTEMS, INC.
AAPL vs CSCO
Walgreens Boots Alliance, Inc.
AAPL vs WBA
UNITEDHEALTH GROUP INC
AAPL vs UNH
Walmart Inc.
AAPL vs WMT
Cigna Group
AAPL vs CI
HUMANA INC
AAPL vs HUM
Elevance Health, Inc.
AAPL vs ELV
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe CVS comparison is valid and AAPL should trade closer to CVS on earnings multiple despite its much stronger margins and ROIC, then the stock looks undervalued on a relative P/E basis; if you think the historical band and DCF range are more relevant, then the current price already looks rich.
On the provided P/E framework, AAPL is priced to an implied $562.61 versus a current price of $307.89, implying 82.7% upside. However, that signal is paired with an unusual CVS set: CVS trades at a higher P/E of 75.4x despite much weaker profitability, so the relative valuation gap is driven more by multiple mismatch than by comparable operating quality.
Supporting Metrics